A B S T R A C T In this study we have investigated, in four normal males the effects of dietary saturated and polyunsaturated fat on the chemical composition and thermotropic properties of human high density lipoproteins (HDL) and have measured the influence of the diets on the metabolism of that fraction of HDL apolipoprotein A-I (apoA-I) that undergoes exchange in vitro and accounts for approximately twothirds of the lipoprotein's apoA-I complement. When compared with the saturated fat diet, the polyunsaturated diet reduced plasma cholesterol (24%, P < 0.01) by affecting the cholesterol content in the very low density lipoprotein (125%, P < 0.02), low density lipoprotein (120%, P < 0.01), and high density lipoprotein fractions (133%, P < 0.01). Plasma triglyceride was also lowered (by 13%, P < 0.01). Furthermore, polyunsaturated fat ingestion caused a significant fall in the palmitate and stearate content of HDL triglyceride (41 and 37%, respectively), cholesteryl esters (29 and 35%), and phospholipids (17 and 9%) with a concomitant increase in the linoleate content of these moieties (157, 28, and 29%, respectively). The polyunsaturated diet also produced reciprocal changes in the percentage protein (19%, P <0.02) and phospholipid (411.5%, P < 0.01) in HDL. These compositional changes were associated with an increase in the microscopic fluidity of the polyunsaturated HDL, although both diets had little effect on the fluidity parameters of HDL at body temperature. Rate zonal ultracentrifugation indicated that the HDLJHDL3 ratio fell by 28% (P < 0.05) on the polyunsaturated fat diet. In addition to the above,
INTRODUCTION
Over the last 60 yr, the per capita consumption of polyunsaturated fats has increased by 300% in the United States (2) . The impetus for this change was provided by a number of human (3) (4) (5) (6) and animal (7) (8) (9) (10) studies that showed that the ingestion of saturated fats leads to an elevation of plasma cholesterol, whereas polyunsaturated fats produce the opposite effect. Widespread acceptance of this effect of diet modification has led to recommendations from the American Heart Association (11), the American Health Foundation (12) , the Food and Nutrition Board of the National Research Council, and the American Medical Association (13) advocating changes in diet which include reduction of the total consumption of fat and cholesterol and substitution of polyunsaturated for saturated fat wherever possible.
Although the lipid lowering effects of dietary polyunsaturated fats appear to justify the above recommendations, their metabolic effects are not completely understood. In addition to their hypocholesterolemic action, polyunsaturated fats also cause reduction in plasma triglyceride levels (14) , increased excretion of fecal bile acids (15) , alteration in the positional substitution of acyl groups in plasma triglycerides (16) , and an increase in the proportion of polyunsaturated fatty acids in lipoprotein lipids (17) (18) (19) with resulting changes in the physical properties of the lipoproteins (19) . The implications of these changes in lipoprotein structure relative to the metabolism of the complexes are not yet clear although Engelberg (14) found that lowering of serum triglycerides was correlated with an increase in lipoprotein catabolism, and studies in this laboratory (20, 21) have suggested a relationship between low density lipoprotein apolipoprotein (apoLDL)l catabolism and the fatty acid composition of LDL. To extend these observations, we have compared the effects of saturated vs. polyunsaturated dietary fat on the metabolism of human apolipoprotein A-I.
METHODS
Subjects. Four healthy adult males were studied in the General Clinical Research Center of the Methodist Hospital, Houston. None had clinical or biochemical evidence of cardiac, hepatic, renal, or endocrine disease. No medications were given for 4 wk before and throughout the study. Informed consent was obtained from each subject.
Diets. The effects of two isocaloric diet regimens on high density lipoprotein (HDL) apolipoprotein A-I (apoA-I) metabAbbreviations used in this paper: apoA-I, apolipoprotein A-I, the major apoprotein of high density lipoproteins; HDL, high density lipoproteins, 1 .063 < d < 1.21 kg/liter; LDL, low density lipoproteins, 1.006 < d < 1.063 kg/liter; TEMPO, 2,2,6,6-tetramethyl-piperidine-1-oxyl; VLDL, very low density lipoproteins of d < 1.006 kg/liter. olism were investigated using the protocol outlined in Fig. 1 .
The caloric distribution of both diets was 20% protein, 40% carbohydrate, and 40% fat. The polyunsaturated/saturated fat ratio in study I (diet S) was 0.25 and in study II (diet P), 4 .0. The cholesterol intake on each diet was 400 mg/day. The fatty acid composition of a typical saturated and polyunsaturated meal has been presented elsewhere (19) . All elsewhere (27) we have found that the metabolism of '251-apoA-I intercalated into HDL by in vitro transfer is not directly comparable to that of the apoprotein labeled in the whole HDL particle, the former being catabolized 20% faster than the latter. The apoA-I turnover parameters presented in this report describe the metabolism of that component of HDL apoA-I that exchanges with free apoA-I in vitro (two-thirds of the HDL apoA-I complement). The faster rate of catabolism of this exchangeable apoA-I limits the utility of the HDL labeling technique but should not affect its application to the direct measurement of the influence of dietary fat saturation on the metabolism of the apoprotein.
Chemical analyses. Plasma cholesterol and triglyceride assays, and beta-quantification were performed as described in the Lipid Research Clinics Manual of Laboratory Operations (29) .
Lipoprotein compositions were obtained as follows: Free and esterified cholesterol were measured by enzyme assay (Boehringer cholesterol kit, 15732, Boehringer Mannheim Biochemicals, Indianapolis, Ind.) using Boehringer cholesterol standards; triglyceride by a fluorometric procedure (29) ; phospholipid by phosphorus analysis (30) ; protein by the procedure of Lowry et al. (31) using a human albumin standard (Sigma Chemical Co., St. Louis, Mo.); and fatty acid analysis by gas liquid chromatography (19) .
Spin label paramagnetic resonance studies. Electron paramagnetic resonance studies were performed on HDL as described by Morrisett et al. (19) , using the spin label probe 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO).
ApoA-I electroimmunoassay. A modification of the method of Laurell (32) was used. The procedure is described elsewhere (33) .
Rate zonal ultracentrifugation. At the end of both diet periods, 15 ml of postabsorptive plasma was collected from each subject, and the HDL subfractions separated by rate zonal ultracentrifugation (34) . The relative amount of HDL2 and HDL3 in each plasma sample was quantified from the area subtended by the appropriate segments of the absorption profile. The area of each subfraction peak was expressed as a percentage of the total HDL profile area.
Administration of 1251-apoA-IIHDL and collection of samples. Each subject received 900 mg ofKI daily in divided doses for 3 days before and throughout the period of the turnover study to minimize thyroidal uptake of 1251. A weighed volume of autologous 1251-apoA-I/HDL (25 gCi radioactivity; approximately 1 mg HDL apoprotein) was injected intravenously into each recipient at time zero, and 10-ml fasting venous blood samples were collected into disodium EDTA (1 mg/ml) after 10 min and subsequently at 24-h intervals for 17 days. The plasma volume of each subject was calculated from the isotope dilution that occurred during the first 10 min, after which time mixing was assumed to be complete.
The results were in good agreement with a value of 4% of body weight. Sequential 24-h urine collections, whose completeness was evaluated by measuring creatinine excretion, were made throughout the 17-day period. 2-ml aliquots of the daily plasma and urine specimens were counted in a Packard Autogamma scintillation spectrometer (Packard Instrument Co. Inc., Downers Grove, Ill.) at the end of the turnover study to eliminate the need to correct for radioactive decay. Counting time was adjusted to reduce counting error to <±2%. Every 3rd day, lipoprotein cholesterol, triglyceride, and apoA-I assays were performed on each plasma sample; and on days 1, 6, 13, the distribution of the 1251-apoA-I among the plasma lipoproteins was determined (35) by 6% agarose gel chromatography (Bio-Gel ASm, 200-400 mesh, Bio-Rad Laboratories, Richmond, Calif.). At the end of each diet period, and after completion of the turnover studies, 100 ml of fasting plasma was obtained from each subject to isolate HDL (22) . After recentrifugation, the HDL was used in chemical and physical studies.
Each individual was studied twice, first on diet S, then on diet P, the time interval between the two study periods being 5 wk.
Data handling. The plasma radioactivity clearance data were processed as described before (36) using the multicompartmental procedure of Matthews (37) . Under steadystate conditions, this permits calculation of the fractional catabolic rate of the radioiodinated apoprotein (i.e., the fraction of the intravascular pool catabolized per day). This kinetic parameter can be estimated by an independent method (38) which expresses the fractional catabolic rate as the ratio of the total radioactivity excreted in the urine during each 24-h period to the mean plasma radioactivity in this period (i.e., the urine/plasma radioactivity ratio).
RESULTS
The validity of this study of the influence of dietary fat saturation levels on the structure of HDL and on Table I . The polyunsaturated fat produced significant reductions in total plasma cholesterol and triglyceride and also reduced the plasma levels of cholesterol associated with very low density lipoprotein (VLDL), LDL, and HDL. These findings, on the whole, corroborate and amplify the observations of other workers (3-8, 14, 15) and raise the possibility that the observed changes in the plasma lipid concentrations may be accompanied by changes in the composition of the plasma lipoproteins. Tables II and III indicate that this is so, at least for HDL. Ingestion As has been shown by others (17) (18) (19) , the polyunsaturated diet increased significantly the proportion of polyunsaturated fatty acids in the cholesteryl esters, triglycerides, and phospholipids of HDL, and de- ) ; the percentages of the first three fatty acids were significantly reduced in each lipid class as a result of the polyunsaturated fat diet (except in phospholipid oleate which was not significantly changed by diet treatment), whereas linoleate was uniformly increased in the HDL lipid fractions. These changes reflect the fatty acid composition of each diet. Overall, HDL triglycerides were most affected by polyunsaturated f:at ingestion whereas phospholipids showed the least change. We predicted that these changes in saturation of the fatty acyl chains in HDL produced by polyunsaturated fat ingestion would result in significant changes in the microscopic fluidity of the lipoproteins. This prediction was confirmed by electron spin resonance studies of HDL isolated from the subjects' plasma at the end of each diet period. The amphiphilic spin label used (TEMPO) demonstrates temperature-dependent partitioning between the bulk aqueous phase and fluid lipid phase of lipoproteins that can be quantified from the amplitude changes evident in the hydrophobic and polar components of the TEMPO spectrum high field resonance line. Plots of the fluidity parameter, f, calculated from such spectra, vs. temperature indicate that lipoproteins, presumably because of their complexity, do not exhibit sharp phase transition temperatures. However, Arrhenius plots of ln f vs. 1/T gave a characteristic discontinuity for HDL as shown in Fig. 2 . The transition temperatures for HDL obtained after both dietary regimens are presented in Table IV . Phase transition occurred at approximately 26 .5°and 180C on the saturated and polyunsaturated diets, respectively.
The parameters used to define the maintenance of steady state during both phases of this metabolic study Determinations were made on plasma collected on days 1, 6, and 13 after injection. * Plasma lipoproteins were prepared by ultracentrifugation at d = 1.225 kg/liter and the percentage of total plasma radioactivity associated with the fraction determined.
t Plasma lipoproteins, prepared as described above, were chromatographed on a column containing 6% agarose and the percentage radioactivity associated with the HDL fraction determined.
are presented in Table V and include body weight, plasma apoA-I concentrations, and urine/plasma radioactivity ratios. Throughout both study periods, variation in daily body weight did not exceed 1% of the mean value for any subject. The variability of daily urine/plasma radioactivity ratios and of plasma apoA-I levels measured on five occasions throughout each study was 15.3 and 6.25%, respectively, from the mean value. We believe that these findings, when taken together, justify the conclusion that a steady state was maintained throughout both studies and consequently, the application of Matthews' (37) compartmental analysis procedure was warranted. Ultracentrifugal flotation performed on plasma from each volunteer on day 1, 6 , and 13 after injection demonstrated that the '251-apoA-I retained its association with a plasma component of < 1.225 kg/liter throughout both study periods. Overall, on the polyunsaturated diet, a mean of 93.2+8% of the total radioactivity appeared at the top of the centrifuge tube (Fig.  3A , Table VI ). Gel filtration of this material through 6% agarose demonstrated that 96.0+1.5% of the radioactivity that floated had the elution characteristics of HDL (Fig. 3B , Table VI "Ratio of 24 h urinary radioactivity to mean plasma radioactivity in the same time period. ¶ The product of calculated fractional catabolic rate and apoA-I pool size. ** Absolute rate of catabolism of apoA-I (in milligrams per day) divided by body weight (in kilograms).
t I Paired t test.
we concluded that the injected 1251-apoA-I/HDL tracer maintained its integrity throughout the study periods, and this conclusion was substantiated by the finding that the injected radioactivity was distributed in the body in a manner consistent with its continued association with a high molecular weight species. A typical 1251-apoA-I/HDL plasma decay curve is shown in Fig. 4 and, like the decay profile for LDL (36) , can be adequately described by two exponential components whose slopes and y-axis intercepts were used to calculate the fractional catabolic rate of the 1251-apoA-I/HDL (37) . The urine/plasma radioactivity ratio, measured at daily intervals throughout the study, provided an independent assessment of the same kinetic parameter (38) . The constancy of this ratio is a useful monitor of steady-state and tracer homogeneity during the period of study (see Table V ). The kinetic data calculated are presented in Table VII . It is evident that polyunsaturated fat therapy produced a significant reduction (P < 0.01) in the plasma apoA-I level. This effect may have been caused by increased catabolism or decreased synthesis of the apoprotein, or by a combination of both. As no increase in the fractional rate of catabolism of the exchangeable apoA-I could be demonstrated either by calculation from the plasma data or by direct measurements of the urine/plasma ratio, we infer that the synthetic rate of the apoprotein (which is equivalent to the absolute catabolic rate under steady-state conditions) is lowered as a result of the polyunsaturated fat diet.
The change produced in plasma apoA-I levels by ingestion of the diet high in polyunsaturated fat had an effect on the distribution of the HDL subfractions (HDL2 and HDL3) in the plasma. Specifically, there was a 28% fall in the HDL2:HDL3 plasma ratio during polyunsaturated fat feeding (Table VIII) .
DISCUSSION
That ingestion of polyunsaturated fat by normal subjects causes a reduction in plasma cholesterol, triglyceride, and phospholipid is well documented (3-6, 14, 15, 39, 40) . The cholesterol-lowering effect has been shown to result largely from a decrease in plasma LDL. Some investigators have claimed that a fall in HDL cholesterol also contributes to this effect (40) , although others have failed to confirm this observation (39, 41) . Our findings in healthy young males (Table I) indicate that 60% of the polyunsaturated fat-induced cholesterol lowering resulted from a reduction in the LDL fraction, augmented by significant decreases in VLDL and HDL cholesterol (producing 8 and 32% of the reduction, respectively).
Analysis of the composition of plasma HDL at the end of both diet periods (Table II) (19) . However, on the saturated diet, the transition temperatures we observed were significantly lower than in this earlier study. This difference may be explained by the fact that on the saturated diet, the HDL phospholipids from the study of Morrisett et al. contained 38% less linoleic acid than we observed (Table III) . The reason for these differences is the variability in individual response to modification of the saturation level of dietary fat. Because the phase transitions on both diets occurred well below body temperature, and at 37°C the fluidity parameters were not significantly different (Fig. 2) , the observed alteration of apoA-I metabolism could not be explained on the basis of this physical parameter.
Previous studies suggest that changes in the fatty acid composition of lipoproteins may influence directly their rate of catabolism. For example, Thompson et al. (20) , by intralipid infusion, increased the oleate:linoleate ratio in LDL cholesteryl esters and demonstrated a decrease in LDL apoprotein catabolism. Also, Soutar and co-workers (42) showed that the rate of acyl group transfer by lecithin:cholesterol acyl transferase, an enzyme intimately associated with HDL metabolism (43) , was dependent on the fatty acid component of the substrate. Furthermore, lipoprotein lipase, another major enzyme involved in lipoprotein metabolism, hydrolyzes unsaturated triglycerides faster than saturated triglycerides (44) . We expected that the dietinduced alterations in HDL lipid saturation might produce changes in catabolism of the lipoprotein and of its major apoprotein, apoA-I, which would account for the fall in plasma HDL we observed. It is evident from Table VII that catabolism of apoA-I as measured by the method reported here was not affected by the change in diet. On the contrary ingestion of the polyunsaturated diet was associated with a decreased rate of synthesis of this apoprotein. In other words, polyunsaturated fat feeding appears not to exert its effect upon apoA-I catabolism, secondary to alterations of the physicochemical properties of HDL but rather by modifying the rate of apoA-I synthesis or secretion or both.
Our observations are germane to the therapeutic efficacy of polyunsaturated fats in combating the development of atherosclerotic heart disease. The undoubted hypocholesterolemic effect of this treatment (with its implied benefits) must be weighed against the potentially detrimental reduction in HDL because this lipoprotein is widely believed (45, 46) to have antiatherogenic properties. However, we must make it clear that the diets in this study were extreme examples of those normally encountered in current clinical practice. The data presented here provide a base line for further studies designed to quantify the effects of polyunsaturated fat diets.
